Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

The AI Test combines clinical data and digital pathology to calculate prognostic risk scores and determine the risk of distant metastasis or prostate cancer-specific mortality within 10 years. It is ...

Opens in a new tab or window A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with ...

assessment of the drug's biochemical and physiological effects on the body and its mechanism of action against cancer cells. Key inclusion criteria for the study includes patients who are 18 years or ...